Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease

Katherine J Bangen1, Daniel A Nation2, Lisa Delano-Wood3

  • 1Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.

Insights

Multiple vascular risk factors, not individual ones, correlate with cerebrovascular changes (CVCs) in Alzheimer's patients. CVCs were linked to less severe Alzheimer's pathology, suggesting vascular health impacts dementia progression.

Area of Science:

  • Neurology
  • Pathology
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia.
  • Vascular risk factors are implicated in cognitive decline.
  • The interplay between vascular pathology and AD neuropathology requires further investigation.

Purpose of the Study:

  • To investigate the association between antemortem vascular risk factors and postmortem cerebrovascular changes (CVCs) and Alzheimer's disease (AD) pathologies.
  • To determine if aggregate vascular risk influences CVCs and AD severity.

Main Methods:

  • Eighty-four AD patients' antemortem vascular risk factors were assessed.
  • Postmortem brain autopsies were performed to evaluate CVCs (atherosclerosis, arteriosclerosis, lacunes, microinfarcts) and Braak stage.
  • Individuals with large strokes were excluded to focus on mild CVCs.

Main Results:

  • No single vascular risk factor, excluding stroke/TIA history, was linked to CVCs.
  • A higher number of vascular risk factors was significantly associated with the presence of CVCs.
  • CVCs were associated with a lower Braak and Braak stage, indicating less neurofibrillary tangle pathology.

Conclusions:

  • Aggregate vascular risk is crucial in the vascular contribution to dementia.
  • Maintaining cerebrovascular health may be key to preventing or delaying dementia, even in the presence of AD pathology.
  • These findings underscore the importance of managing multiple vascular risk factors for brain health in aging populations.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
925